Trial opens door for more testing of hepatitis C vaccine

01/9/2012 | Medical News Today

British researchers used an adenoviral vector strategy to develop a vaccine that can strengthen T cells' response against the hepatitis C virus. The study, published in the journal Science Translational Medicine, found the vaccine to be safe. Researchers are working on a second-stage trial among people infected with the virus, and a U.S. trial is being planned to study whether the vaccine can protect people at risk of infection.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT